首页> 外文期刊>Journal of Pharmaceutics >Self-Microemulsifying Drug Delivery System: Formulation and Study Intestinal Permeability of Ibuprofen in Rats
【24h】

Self-Microemulsifying Drug Delivery System: Formulation and Study Intestinal Permeability of Ibuprofen in Rats

机译:自微乳化药物输送系统:布洛芬在大鼠体内的配方和研究肠通透性

获取原文
       

摘要

The study was aimed at developing a self-microemulsifying drug delivery system (SMEDDS) of Ibuprofen for investigating its intestinal transport behavior using the single-pass intestinal perfusion (SPIP) method in rat.Methods. Ibuprofen loaded SMEDDS (ISMEDDS) was developed and was characterized. The permeability behavior of Ibuprofen over three different concentrations (20, 30, and 40 µg/mL) was studied in each isolated region of rat intestine by SPIP method at a flow rate of 0.2 mL/min. The human intestinal permeability was predicted using the Lawrence compartment absorption and transit (CAT) model since effective permeability coefficients (Peff) values for rat are highly correlated with those of human, and comparative intestinal permeability of Ibuprofen was carried out with plain drug suspension (PDS) and marketed formulation (MF).Results. The developed ISMEDDS was stable, emulsified upon mild agitation with 44.4 nm ± 2.13 and 98.86% ± 1.21 as globule size and drug content, respectively. HigherPeffin colon with no significantPeffdifference in jejunum, duodenum, and ileum was observed. The estimated human absorption of Ibuprofen for the SMEDDS was higher than that for PDS and MF(P<0.01).Conclusion. Developed ISMEDDS would possibly be advantageous in terms of minimized side effect, increased bioavailability, and hence the patient compliance.
机译:该研究旨在开发布洛芬的自微乳化药物递送系统(SMEDDS),以通过大鼠单次肠道灌注(SPIP)方法研究其肠道运输行为。开发并表征了布洛芬负载的SMEDDS(ISMEDDS)。用SPIP方法以0.2μmL/ min的流速研究了大鼠肠道每个分离区域中布洛芬在三种不同浓度(20、30和40μg/ mL)下的渗透行为。由于大鼠的有效渗透系数(Peff)值与人的渗透系数高度相关,因此使用劳伦斯隔室吸收和转运(CAT)模型预测了人的肠渗透性,而布洛芬的比较性肠渗透性是通过普通药物悬浮液(PDS)进行的)和上市配方(MF)。所开发的ISMEDDS是稳定的,在轻微搅拌下乳化,其球大小和药物含量分别为44.4 nm±2.13和98.86%±1.21。观察到较高的Peffin结肠在空肠,十二指肠和回肠中无明显Peff差异。 SMEDDS对布洛芬的人体吸收估计值高于PDS和MF(P <0.01)。在减少副作用,增加生物利用度以及因此患者依从性方面,发达的ISMEDDS可能是有利的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号